×
About 163 results

ALLMedicine™ Acneiform Eruptions Center

Research & Reviews  77 results

Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induc...
https://doi.org/10.1111/1346-8138.15836
The Journal of Dermatology; Tsutsui K, Kikuchi K et. al.

Mar 8th, 2021 - The most common adverse event of epidermal growth factor receptor inhibitors, used to treat colorectal, non-small cell lung, and head and neck cancers, is acneiform eruption, with a profound effect on treatment continuation. Prolonged acneiform er...

Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors...
https://doi.org/10.1159/000513233
Dermatology (Basel, Switzerland); Gisondi P, Geat D et. al.

Jan 28th, 2021 - Epidermal growth factor receptor (EGFR) inhibitors are routinely used in advanced non-small-cell lung cancer (NSCLC) harboring EGFR mutations. However, their use is associated with gastrointestinal and cutaneous toxicities, including acneiform eru...

Efficacy of treatment for acneiform eruptions related to epidermal growth factor recept...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793452
Medicine He C, Lin R et. al.

Jan 12th, 2021 - Acneiform eruptions from epidermal growth factor receptor tyrosine kinase inhibitors is a frequent adverse event in non-small cell lung cancer patients but the efficacy of its treatment including antibiotics, corticosteroid, sunscreen is still poo...

Choosing between isotretinoin and acitretin for epidermal growth factor receptor inhibi...
https://doi.org/10.1016/j.jaad.2020.09.090
Journal of the American Academy of Dermatology; Costello CM, Hill HE et. al.

Oct 11th, 2020 - Choosing between isotretinoin and acitretin for epidermal growth factor receptor inhibitor and small molecule tyrosine kinase inhibitor acneiform eruptions.|2020|Costello CM,Hill HE,Brumfiel CM,Yang YW,Swanson DL,|

Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.
https://doi.org/10.1136/postgradmedj-2020-137756
Postgraduate Medical Journal; Priyam P, Sil A et. al.

Apr 18th, 2020 - Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.|2020|Priyam P,Sil A,Bhanja DB,Mondol DK,|

see more →

Clinicaltrials.gov  81 results

Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induc...
https://doi.org/10.1111/1346-8138.15836
The Journal of Dermatology; Tsutsui K, Kikuchi K et. al.

Mar 8th, 2021 - The most common adverse event of epidermal growth factor receptor inhibitors, used to treat colorectal, non-small cell lung, and head and neck cancers, is acneiform eruption, with a profound effect on treatment continuation. Prolonged acneiform er...

Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors...
https://doi.org/10.1159/000513233
Dermatology (Basel, Switzerland); Gisondi P, Geat D et. al.

Jan 28th, 2021 - Epidermal growth factor receptor (EGFR) inhibitors are routinely used in advanced non-small-cell lung cancer (NSCLC) harboring EGFR mutations. However, their use is associated with gastrointestinal and cutaneous toxicities, including acneiform eru...

Efficacy of treatment for acneiform eruptions related to epidermal growth factor recept...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793452
Medicine He C, Lin R et. al.

Jan 12th, 2021 - Acneiform eruptions from epidermal growth factor receptor tyrosine kinase inhibitors is a frequent adverse event in non-small cell lung cancer patients but the efficacy of its treatment including antibiotics, corticosteroid, sunscreen is still poo...

Choosing between isotretinoin and acitretin for epidermal growth factor receptor inhibi...
https://doi.org/10.1016/j.jaad.2020.09.090
Journal of the American Academy of Dermatology; Costello CM, Hill HE et. al.

Oct 11th, 2020 - Choosing between isotretinoin and acitretin for epidermal growth factor receptor inhibitor and small molecule tyrosine kinase inhibitor acneiform eruptions.|2020|Costello CM,Hill HE,Brumfiel CM,Yang YW,Swanson DL,|

Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.
https://doi.org/10.1136/postgradmedj-2020-137756
Postgraduate Medical Journal; Priyam P, Sil A et. al.

Apr 18th, 2020 - Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.|2020|Priyam P,Sil A,Bhanja DB,Mondol DK,|

see more →

News  5 results

Subungual Hemorrhage From an Epidermal Growth Factor Receptor Inhibitor
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor?channel=44
Josh A. Hammel, MD, Dean Elhag, MD et. al.

Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.

Cutaneous Side-effects of EGFR Inhibitors and Their Management
https://www.medscape.com/viewarticle/742542

Abstract and Introduction Abstract Epidermal growth factor receptor (EGFR) inhibitors are an increasingly important treatment option for metastasized cancer in patients. In addition to the pivotal role of EGFR in the development and progression of...

Cutaneous Side-effects of EGFR Inhibitors and Their Management
https://www.medscape.com/viewarticle/742542_7

Conclusion EGFR inhibitors are associated with a unique group of class- specific cutaneous toxicities, which include acneiform eruptions, paronychia, xerosis, hyperpigmentation, trichomegaly, and telangiectasia. As the use of EGFR inhibitors incre...

see more →